652 related articles for article (PubMed ID: 35794625)
21. Tumor metabolic crosstalk and immunotherapy.
Zhang Y; Nie Y; Liu X; Wan X; Shi Y; Zhang K; Wu P; He J
Clin Transl Oncol; 2024 Apr; 26(4):797-807. PubMed ID: 37740892
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.
Liu K; Cui JJ; Zhan Y; Ouyang QY; Lu QS; Yang DH; Li XP; Yin JY
Mol Cancer; 2022 Apr; 21(1):98. PubMed ID: 35410257
[TBL] [Abstract][Full Text] [Related]
23. The updated landscape of tumor microenvironment and drug repurposing.
Jin MZ; Jin WL
Signal Transduct Target Ther; 2020 Aug; 5(1):166. PubMed ID: 32843638
[TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Molecular Characterization of m
Zhu J; Xiao J; Wang M; Hu D
Front Oncol; 2020; 10():618374. PubMed ID: 33585244
[TBL] [Abstract][Full Text] [Related]
25. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.
Tuccitto A; Shahaj E; Vergani E; Ferro S; Huber V; Rodolfo M; Castelli C; Rivoltini L; Vallacchi V
Virchows Arch; 2019 Apr; 474(4):407-420. PubMed ID: 30374798
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.
Guo W; Qiao T; Dong B; Li T; Liu Q; Xu X
Front Immunol; 2022; 13():915985. PubMed ID: 35812406
[TBL] [Abstract][Full Text] [Related]
28. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
Jia Z; Jia J; Yao L; Li Z
Front Immunol; 2022; 13():900155. PubMed ID: 35663957
[TBL] [Abstract][Full Text] [Related]
30. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs in the Tumor Microenvironment.
Patil N; Allgayer H; Leupold JH
Adv Exp Med Biol; 2020; 1277():1-31. PubMed ID: 33119862
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
33. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S
Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344
[TBL] [Abstract][Full Text] [Related]
34. Analysis of RNA m
Zhao Y; Sun H; Zheng J; Shao C
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):407-435. PubMed ID: 33905280
[TBL] [Abstract][Full Text] [Related]
35. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia.
Han S; Qi J; Fang K; Wang H; Tang Y; Wu D; Han Y
Cancer Med; 2022 Mar; 11(5):1413-1426. PubMed ID: 35023630
[TBL] [Abstract][Full Text] [Related]
36. Interplay within tumor microenvironment orchestrates neoplastic RNA metabolism and transcriptome diversity.
Natua S; Dhamdhere SG; Mutnuru SA; Shukla S
Wiley Interdiscip Rev RNA; 2022 Mar; 13(2):e1676. PubMed ID: 34109748
[TBL] [Abstract][Full Text] [Related]
37. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Ye W; Huang T
PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
[TBL] [Abstract][Full Text] [Related]
38. Exosomes: Critical Mediators of Tumour Microenvironment Reprogramming.
Malla RR; Shailender G; Kamal MA
Curr Med Chem; 2021; 28(39):8182-8202. PubMed ID: 33334279
[TBL] [Abstract][Full Text] [Related]
39. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
Front Immunol; 2022; 13():819080. PubMed ID: 35359993
[TBL] [Abstract][Full Text] [Related]
40. RNA Modifications in Cancer Metabolism and Tumor Microenvironment.
Qing Y; Wu D; Deng X; Chen J; Su R
Cancer Treat Res; 2023; 190():3-24. PubMed ID: 38112997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
